OPTIFERRIN
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 13 Feb 2025)
What this means for you
Registered since 14 May 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88098713
- Registration number
- 5749577
- Mark type
- Design + words
- Filed
- 30 Aug 2018
- Published for opposition
- 26 Feb 2019
- Registered
- 14 May 2019
- Attorney of record
- Crissa A. Cook
Goods and services
- Class 001 — Chemicals: Recombinant transferrin derived from a non-mammalian host for industrial use, namely, for use in the manufacture of cell culture media, pharmaceutical excipients, vaccines, gene therapy preparations, and preparations for cell and tissue storage and processing, and for use in scientific research and bioprocessing
Owner
- INVITRIA, INC., JUNCTION CITY, KS, US
- Ventria Bioscience Inc., Junction City, KS, US
- Ventria Bioscience Inc., Junction City, KS, US
- Ventria Bioscience Inc., Junction City, KS, US
Prosecution history
- 13 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 13 Feb 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 12 Feb 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 Oct 2024 — TEAS SECTION 8 & 15 RECEIVED
- 14 May 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 13 Sept 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 14 May 2019 — REGISTERED-PRINCIPAL REGISTER
- 26 Feb 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Feb 2019 — PUBLISHED FOR OPPOSITION
- 06 Feb 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Jan 2019 — ASSIGNED TO LIE
- 27 Dec 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Dec 2018 — EXAMINER'S AMENDMENT ENTERED
- 19 Dec 2018 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 19 Dec 2018 — EXAMINERS AMENDMENT E-MAILED